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Editorial Commenta rx/
1982: A new start for the Journal
Many of you will have noticed in the fourth issue of Volume 3
that the Journal has recently been acquired by Taylor & Francis
Ltd. This will add the considerable experience of a scientific
publisher, founded in 1798 with over 30journals already in their
portfolio, to the active editorial team established by myself and
United Trade Press. During its first three years, Journal of
Automatic Chemistry has grown at a steady rate, both in terms of
content and subscription and advertising income. am grateful
to United Trade Press for their support in founding the Journal.
Taylor & Francis Ltd, together with the existing Editorial
Board, aim to increase the subscription level by introducing the
Journal to a wider audience. The content will continue to be
vigorously refereed, although the turn round time from receipt of
paper to publication will be improved. The size of the Journal
and its frequency will also be reviewed over the ensuing year. In
order to cater for the real needs ofthe readership, it is important
for you, the reader, to let us know either directly or through
members of the Corresponding Editorial Board your views of
the Journal. Are there areas that you would like covered, but at
present are not being addressed?
What has the Journal achieved?
In its short life, the Journal has achieved some success and
status--recently in Nature (October 1981) Professor T. S. West
wrote:
Each issue contains about eight or nine articles, many of
them devoted to microprocessors and a smaller number
to improvements to commercial automated systems or
the construction of miscellaneous ancillary devices to
improve their performance. In addition there are useful
and informative articles on meetings, new products and
literature, and a running calendar of current and forth-
coming events. There are also occasional book reviews.
The standard of the papers is usually good, even
excellent, and the ’virtual’ A4 format allows good use to be
made of illustrations. The generally high quality of the
articles read in the sample issues suggests that thisjournal
has so far done an excellentjob and should be scanned on
a regular basis by all who are concerned with automation.
It is not possible, since the dates are not given, to establish
publication times, but the journal gives the impression of
being very much ’on the ball’.
This shows that the aims and objectives the Editorial Board set
out to achieve when Journal of Automatic Chemistry was
launched have been met. However, in such a changing area it is
important to keep abreast of the technology. This we will
endeavour to do by submitted articles, by evocative and
informative commentaries, both from Editorial Board members
and from invited specialists, and by review articles. The
enthusiasm and experience of our new publisher will be a
considerable asset as the Journal develops.
Peter B. Stockweil
Acceptable performance standards for
clinical laboratory methods
Many of the instruments and methods used in clinical labora-
tories have been selected for somewhat subjective reasons, such
as low cost and ease of performance, rather than as a result of
objective evaluation of their analytical performance. The usual
clinical laboratory quality-control procedures monitor perform-
ance characteristics such as imprecision and inaccuracy in order
to detect changes in performance, but they cannot improve an
analytical instrument or method which is basically unsound [ 1].
Therefore, an essential part and first step of a total laboratory
quality-control programme should be the evaluation of ana-
lytical instruments or methods before their introduction into the
routine diagnostic service laboratory.
New analytical instruments and reagent kits are introduced
each year. Evaluation of their performance characteristics is a
complex procedure which requires considerable expertise,
skilled staff, ample space and time resources, and suitable patient
samples and comparative methods. There are many published
protocols for evaluation; these have been recently discussed in
detail by Westgard [2]. Although no protocol is universally
applicable, most protocols proposed in the literature follow a
similar pattern. The majority ofpublished evaluations conform,
in general experimental design, to this pattern. Therefore,
evaluations cannot be performed by all potential purchasers and
many must rely for guidance on objective reports in the
literature, or the experience of professional colleagues.
A major problem with published evaluation protocols is that
definitive criteria for acceptability of the performance charac-
teristics are not delineated. Indeed, many evaluations of instru-
ments, reagent kits, and methods document in great detail all
aspects of analytical performance, but fail to assess in an
objective manner whether the performance found is truly
suitable for clinical laboratory use.
It has been stated that one ofthe major current philosophical
problems in clinical biochemistry is the assessment of the
standard of analytical performance that is actually required
to provide optimal patient care at least expense [3]. Such
standards have been termed analytical 9oals. One of the major
difficulties in the setting of such goals is that clinical bio-
chemistry tests are used in many different clinical settings, such
as in aiding diagnosis, in screening, in assessment of the efficacy
of therapy and in emergency situations. This has led some
clinical biochemists to consider the definition of numerical
analytical goals to be an insoluble problem; for example, the.
Expert Panel on Nomenclature and Principles of Quality
Control of the International Federation of Clinical Chemistry
state that a single set ofperformance characteristics is unlikely to
be applicable to all of the situations in which tests are used [1].
However, analytical goals for a number ofperformance charac-
teristics have been documented in the literature; this subject has
been recently reviewed [4].
Most work has been concerned with the delineation of
analytical goals for imprecision; this is considered to be
appropriate since analytical imprecision cannot be avoided.
Strategies for the derivation of goals for imprecision have been
classified as being based on (1) the reference range; (2) biological
variation; (3) the views ofclinicians; (4) the state ofthe art; (5) the
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consensus opinions of expert groups; and (6) the views of
individuals. The recommendations made by Barnett [5], which
are based upon a synthesis ofopinion of clinical and laboratory
specialists, are probably the most widely adopted. However, the
current view would be that goals for the imprecision of plasma
analyses are best derived from intra-individual biological
variation. Ifbiological variation data.are unavailable, then goals
should be derived from the state ofthe art achieved by a selected
group of better laboratories. Goals based upon biological
variation have been recently summarized by the Subcommittee
on Analytical Goals in Clinical Chemistry of the World
Association of Societies of Pathology [6] and summaries of the
current performance attained by better laboratories have been
documented by Stevens and Cresswell [7].
There has been little work performed on setting analytical
goals for the imprecision of analyses of biological fluids other
than plasma or serum. Goals for the analysis ofcommon urine
constituents have been derived from biological variation, the
state ofthe art and surveys ofclinical opinion [8]. It appears that
the biological variation strategy is not totally applicable for this
biological fluid and it has been suggested that, since all the
current strategies adopted for the delineation of goals do have
disadvantages, the most stringent goals obtained should be
applied.
Goals for inaccuracy have been delineated by few authors. It
is generally believed that, at the present time, clinical labora-
tories should be attempting to eliminate bias from their results in
order to make results as far as possible comparable over time
and geography. Therefore, the goal for inaccuracy is that
methods should have no bias.
Imprecision is usually defined to mean random analytical
error, while systematic error is called inaccuracy or bias.
However, bias can be considered to have two components:
systematic bias, which reflects the difference between results
found and their true values; and random bias, which reflects
non-constant changes in inaccuracy brought about by, for
example, changing the vials of a calibrator for every analytical
batch. Thus, it is difficult to fully separate inaccuracy from
imprecision. It may therefore be of advantage to consider the
goals promulgated as goals for imprecision as goals for total
analytical error. The total error concept [9] also facilitates
communication with clinical staffand manufacturers; it is hoped
that this concept will become much more widely used by clinical
biochemists.
A thorough evaluation also investigates performance
characteristics such as detection limit and turnaround time.
Goals for these characteristics should also be used, wherever
possible, for objective analysis of experimental data. There are,
however, few publications concerning facets of the discipline
such as these. It is hoped that work in these and further areas will
be performed in the near future.
The derivation of analytical goals for all facets of clinical
laboratory analyses is itself a fascinating subject, but it is the
sound application of goals that will ultimately benefit patient
care. Goals should be used in individual laboratories in order to
assess their quality-control results; comparison of found per-
formance with analytical goals should allow laboratories to pick
out those methods which require improvement. Goals should
also be used in the setting of acceptable standards of perform-
ance by accreditation or other regulatory agencies. Laboratories
could use a comparison of their performance with published
goals as an additional lever to obtain new analytical equipment.
Published goals could aid laboratories in communication with
clinicians if allegations that a particular laboratory test was
inadequate were to be refuted in an objective manner, provided
that the goals were met. Manufacturers ofanalytical instruments
and reagent kits have played a notable role in the development
of clinical biochemistry and it could be argued that the present
analytical state of the art has been, in large part, set by
commercial interests; it is believed that analytical goals, set by
the profession, should be taken very much into account when
manufacturers develop new instruments or kits and when
laboratories are considering the purchase of new analytical
techniques. Finally, it is surely no longer satisfactory for
published evaluations ofinstruments and reagent kits to merely
use professional judgement or the specifications of the manu-
facturer as criteria of acceptability; it is firmly believed that it
should be mandatory for all evaluators to carefully compare the
performance obtained with analytical goals and to make
objective judgement on the acceptability, or otherwise, of as
many of the performance characteristics as possible.
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